MOG and ocular melanoma: Supporting studies in B6 mice showed that OM-MOG treatment is associated with a peripheral type 2 myeloid cell response, induction of T cell anergy, preservation of axons within lesions and increased expression of genes associated with recovery of myelin and neurons in the spinal cord.